Kaya Limited: SEBI Takeover Disclosure under Regulation 31(4)
Kaya Limited, a multi-specialty healthcare and aesthetic services operator, submitted a disclosure of substantial acquisition to NSE on 30 June 2026 under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing indicates a shareholder acquisition event meeting the 5% disclosure threshold. The acquirer identity, consideration, and final shareholding percentage are not disclosed in the regulatory notice itself; these details are contained in the full Form DIS-4 filed with the exchange.
Why it mattersRegulation 31(4) disclosure is triggered upon acquisition of 5% or more shares, requiring the acquirer to make open-market purchases transparent; this filing confirms the transaction crossed the statutory threshold for takeover code applicability and competitor/shareholder access under SEBI rules.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives - Kaya Limited Takeover Disclosure · official
- SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026